Insights

Strategic Partnerships Specifica has established collaboration with Servier and Symphogen and recently expanded AbXtract in partnership with OpenEye. This indicates a strong channel for co-development, licensing, or platform transfer deals and presents a sales opportunity to propose joint programs or expanded library capabilities to pharma companies seeking integrated discovery platforms.

Gen 3 Platform The Generation 3 antibody discovery platform emphasizes broad diversity, high affinities, and low biophysical liabilities from naïve libraries. This can be pitched to biotech teams aiming to accelerate lead generation, reduce optimization time, and improve success rates in early discovery stages.

Informatic Tools Launch of AbXtract and its integration with partners signals a growing emphasis on antibody informatics. There is a sales angle for offering informatics-enabled discovery support, data analysis services, and software-enabled optimization that complements wet-lab capabilities for customers seeking faster time-to-lead.

Global Expansion Transfers and partnerships with major players (Sanofi, Servier) suggest interest in scaling production and discovery globally. This presents opportunities to position Specifica as a cross-border collaboration partner for multinational pharma companies requiring scalable library design and platform access.

Growth Readiness With a revenue range of 25-50 million and a lean employee base, Specifica appears agile and investment-friendly for strategic collaborations, equity partnerships, or minority investments to accelerate platform adoption, expand services, and broaden library customization offerings.

Similar companies to Specifica, an IQVIA business

Specifica, an IQVIA business Tech Stack

Specifica, an IQVIA business uses 8 technology products and services including iCIMS, WordPress, OneTrust, and more. Explore Specifica, an IQVIA business's tech stack below.

Media & News

Specifica, an IQVIA business's Email Address Formats

Specifica, an IQVIA business uses at least 1 email format:
Specifica, an IQVIA business Email FormatsExamplePercentage
FLast@specifica.bioJDoe@specifica.bio
100%

Frequently Asked Questions

What is Specifica, an IQVIA business's official website and social media links?

Minus sign iconPlus sign icon
Specifica, an IQVIA business's official website is specifica.bio and has social profiles on LinkedIn.

How much revenue does Specifica, an IQVIA business generate?

Minus sign iconPlus sign icon
As of October 2026, Specifica, an IQVIA business's annual revenue is estimated to be $25M - $50M.

What is Specifica, an IQVIA business's SIC code and NAICS code?

Minus sign iconPlus sign icon
Specifica, an IQVIA business's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Specifica, an IQVIA business have currently?

Minus sign iconPlus sign icon
As of October 2026, Specifica, an IQVIA business has approximately 29 employees across 2 continents, including North America and Europe. Key team members include Research Associate Iii: A. T., Research Scientist: N. L. and : A. B. Explore Specifica, an IQVIA business's employee directory with LeadIQ.

What industry does Specifica, an IQVIA business belong to?

Minus sign iconPlus sign icon
Specifica, an IQVIA business operates in the Biotechnology Research industry.

What technology does Specifica, an IQVIA business use?

Minus sign iconPlus sign icon
Specifica, an IQVIA business's tech stack includes iCIMS, WordPress, OneTrust, Shopify, Microsoft 365, Barracuda Email Protection, Smartsheet and Piwik PRO Core.

What is Specifica, an IQVIA business's email format?

Minus sign iconPlus sign icon
Specifica, an IQVIA business's email format typically follows the pattern of FLast@specifica.bio. Find more Specifica, an IQVIA business email formats with LeadIQ.

When was Specifica, an IQVIA business founded?

Minus sign iconPlus sign icon
Specifica, an IQVIA business was founded in 2016.
Specifica, an IQVIA business logo

Specifica, an IQVIA business

Biotechnology ResearchNew Mexico, United States11-50 Employees

Specifica, an IQVIA business, operates in biotechnology research with a focus on antibody libraries and discovery platforms. Its Generation 3 platform produces drug-like antibodies with broad diversity and high affinities directly from naive libraries, while aiming to minimize biophysical liabilities. In addition to in-house designs, the company collaborates with partners to create customized libraries tailored to their needs. Based in Santa Fe, New Mexico, Specifica has engaged in partnerships with pharmaceutical companies to advance antibody discovery initiatives. In 2023 the company introduced AbXtract, a set of antibody informatics tools, and announced platform-transfer arrangements with Servier and Symphogen.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $25M - $50M

    Specifica, an IQVIA business's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.